CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-08 | LAROSA JOSEPH J EVP General Counsel and Secret | Grant or award · Non-Qualified Stock Option (right to buy) | +7,649 | 7,649 | ||
| 2023-12-08 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −1,013 | $843.79 | $855K | 30,686 |
| 2023-12-08 | Fenimore Christopher R. SVP Controller | Shares withheld for taxes | −474 | $843.79 | $400K | 20,468 |
| 2023-12-08 | Fenimore Christopher R. SVP Controller | Grant or award | +2,370 | 22,838 | ||
| 2023-12-08 | Fenimore Christopher R. SVP Controller | Grant or award · Non-Qualified Stock Option (right to buy) | +8,499 | 8,499 | ||
| 2023-12-08 | Van Plew Daniel P EVP & General Mgr, Industrial | Shares withheld for taxes | −1,108 | $843.79 | $935K | 20,400 |
| 2023-12-08 | Van Plew Daniel P EVP & General Mgr, Industrial | Grant or award | +3,199 | 23,599 | ||
| 2023-12-08 | Van Plew Daniel P EVP & General Mgr, Industrial | Grant or award · Non-Qualified Stock Option (right to buy) | +11,473 | 11,473 | ||
| 2023-12-08 | STAHL NEIL EVP Research and Development | Shares withheld for taxes | −809 | $843.79 | $683K | 51,891 |
| 2023-12-08 | STAHL NEIL EVP Research and Development | Grant or award | +853 | 52,744 | ||
| 2023-12-08 | STAHL NEIL EVP Research and Development | Grant or award · Non-Qualified Stock Option (right to buy) | +3,059 | 3,059 | ||
| 2023-12-08 | MURPHY ANDREW J EVP Research | Shares withheld for taxes | −883 | $843.79 | $745K | 58,538 |
| 2023-12-08 | MURPHY ANDREW J EVP Research | Grant or award | +3,199 | 61,737 | ||
| 2023-12-08 | MURPHY ANDREW J EVP Research | Grant or award · Non-Qualified Stock Option (right to buy) | +11,473 | 11,473 | ||
| 2023-12-08 | McCourt Marion EVP Commercial | Shares withheld for taxes 10b5-1 | −852 | $843.79 | $719K | 18,951 |
| 2023-12-08 | McCourt Marion EVP Commercial | Grant or award 10b5-1 | +2,133 | 21,084 | ||
| 2023-12-08 | McCourt Marion EVP Commercial | Grant or award · Non-Qualified Stock Option (right to buy) 10b5-1 | +7,649 | 7,649 | ||
| 2023-12-05 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −136 | $810.38 | $110K | 65,821 |
| 2023-12-05 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −103 | $811.37 | $84K | 65,718 |
| 2023-12-05 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −372 | $812.57 | $302K | 65,346 |
Page 45 of 49 · 971 trades